Analytical validation of the Target Selector ctDNA platform featuring single copy detection sensitivity for clinically actionable EGFR, BRAF, and KRAS mutations.
Jason C PooleShan-Fu WuTimothy T LuCecile Rose T VibatAnh PhamErrin SamuelszManisha PatelJeffrey ChenTony DaherVeena M SinghLyle J ArnoldPublished in: PloS one (2019)
Highly sensitive Target Selector ctDNA assays with single mutant copy detection and limit of detection at 0.02% or better enable accurate molecular profiling vital for disease management.